What sector does Jfl Life Sciences Limited belong to?

Jfl Life Sciences Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of JFLLIFE?

As of the latest available quote, JFLLIFE traded at ₹51.05. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of JFLLIFE?

Jfl Life Sciences Limited has a price-to-earnings (P/E) ratio of about 26.31. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of JFLLIFE?

The market capitalisation of Jfl Life Sciences Limited is approximately ₹35 Cr.

Is Jfl Life Sciences Limited profitable?

For its latest reported financial year, Jfl Life Sciences Limited recorded a net profit margin of about 4.58%.

Does JFLLIFE pay a dividend?

Jfl Life Sciences Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of JFLLIFE?

Jfl Life Sciences Limited has a return on equity (ROE) of about 15.00%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of JFLLIFE?

Over the past 52 weeks, JFLLIFE has traded between a low of ₹8.55 and a high of ₹15.40.

Jfl Life Sciences Limited

JFLLIFE NSE Healthcare Pharmaceuticals

₹51.05

+0.00%

Delayed · cached 15 min

Fair value analysis

JFLLIFE

Jfl Life Sciences Limited

₹10.65

Close used for this calculation

₹25.63Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

69/100

Profitability17/25

Returns21/25

Balance Sheet9/25

Efficiency22/25

Growth20/25

Strong

Quality radar

Consensus fair value

₹25.63

Below FV

▲ +140.7% against the close used

Model range ₹17.84 – ₹64.51

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹17.84Fair value₹25.63Bull₹64.51

FairClose

52-week traded range

52W low ₹8.5552W high ₹14.70

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Jfl Life Sciences Limited closed at ₹10.65, 58.4% below the consensus fair value of ₹25.63 drawn from 9 valuation models.

Financial DNA score 69/100 — Strong. P/E of 5.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹19.25

+80.8%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹17.84

+67.5%

√(22.5 × EPS × BVPS)

EPS=0.97, BVPS=14.59

Graham Formula

₹43.68

+310.2%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹34.63

+225.2%

EPS × 35.7x (sector P/E)

EPS=0.97, Sector P/E=35.7x

Peter Lynch (PEG)

₹24.25

+127.7%

EPS × Growth% (PEG = 1 is fair)

EPS=0.97, g=25%

EV/EBITDA

₹64.51

+505.7%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=130M

Book Value (P/B)

₹32.83

+208.2%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=14.59, ROE=15%, g=6%, r=10%

Reverse DCF

₹10.65

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -1% | Historical: 25%

Margin of Safety

₹21.64

+103.2%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=28.85, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer